New York, NY -- (SBWIRE) -- 02/14/2013 -- MediSwipe Inc. (OTCQB: MWIP), a patient security solutions and financial products company for the medicinal marijuana and health care industry, announced Friday's ruling in the state of Michigan to no longer allow "patient to patient" dispensary operations will not have a meaningful effect on the overall business strategy of the Company's plans to provide patient and state services in Michigan, or the other 17 legally approved states where the company is seeking to provide its services.
The Michigan Medical Marihuana Program (MMMP) currently only allows patients to buy the drug from registered caregivers, of which there are nearly 26,000 in the state.
MediSwipe Inc. provides innovative patient solutions for electronically processing transactions within the medical marijuana and healthcare industry.
Find out where MWIP could be headed by getting the trend analysis report here: http://www.wallstreetreport.net/market-scan/?symbol=MWIP
Altitude Organic Corporation, a division of Tranzbyte Corporation (OTC Pink: ERBB), announced the findings of research conducted by the company's soil development partner, U-mate International Inc.
U-mate International Technical Director is Russian soil scientist Dr. Vladimir Vasilenko. Dr. Valisenko'shumate research appeared in the publication, Greenhouse Canada in 2001. It found that derivatives of humate products, particularly the fulvic acid fraction, increased the percentage of germination of tomato seeds.
Tranzbyte Corporation, through its subsidiaries, operates independently owned retail dispensaries under the Altitude Organic Medicine brand name in Colorado, California, and Arizona.
Find out more on ERBB here: http://www.wallstreetreport.net/market-scan/?symbol=ERBB
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetReport.net
Disclosure: WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.
BlueLys, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
For full disclaimer visit: www.wallstreetreport.net/disclaimer-2/
WALL STREET REPORT